Shah Preetam
Elicio Therapeutics, Inc. · See Remarks
Shah Preetam is listed in filings as See Remarks at Elicio Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 3, 2026, including 4 public disclosures. Recent filings connect the profile to Elicio Therapeutics, Inc. (ELTX) and Cidara Therapeutics, Inc. (CDTX). The current snapshot covers public activity from Oct 2, 2024 to Feb 3, 2026. Reported amounts are shown as $388.0K to $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||